Ian Chan

Ian Chan is co-founder, CEO of Abpro Corporation. Abpro is a next-generation antibody therapeutics company based in the Boston area. He has been involved in all aspects of building and leading the company, including overseeing all aspects of business, forming strategic partnerships, financing, building the team, platform and also pipeline since 2007. Other prior experiences include co-founding US Genomics and Morgan Stanley. Mr. Chan earned an A.B. in Biology and Economics from Brown University and M.B.A. from the Harvard Business School.